An aging population, growing incidence of chronic disease, and rising costs are driving innovation and restructuring of the US healthcare system. These challenges mean opportunity for companies with products or services that reduce costs and improve outcomes and expand access.
Sverica is an experienced healthcare investor with the industry know-how, contacts, and vision to help innovative healthcare services, health IT, managed care, and life sciences services companies manage through an ever changing healthcare landscape.
- Physician practices
- Alternative, multi-site healthcare
- Consumer-driven healthcare
- Post-acute care
- Pharmacy services
- Outsourced services
- Payor services
- Population health
- Complex care management
- Self-insured plan support
- High deductible plan support
- Software & information services
- Revenue cycle management
- Healthcare analytics
- Telemedicine & Telehealth
Life Science Services
- Contract manufacturing
- Contract research organizations
- Pharma services
- Med-tech services
Women’s Health USA
Founded in 1997, WHUSA provides OBGYN, In Vitro Fertilization, and other specialty women’s health practices with a full suite of practice management solutions including payor contracting, revenue cycle management, EMR support, financial & human resources management, merger & acquisition support, ancillary services development, and risk management services. WHUSA’s unique partnership model enables physicians and physician groups to maintain their independence, while leveraging the resources of a national organization.
In Vitro Sciences
In Vitro Sciences (IVS) partners with reproductive endocrinology practices across the United States. IVS partners to offer strategic opportunities for independent practices, including: implementing creative growth strategies supporting streamlined operational costs, payer alignment, merger and acquisition plans, marketing, and risk management services. Its unique partnership model enables physicians and physician groups to maintain their independence while leveraging the resources of a national organization.
Med First operates healthcare clinics across North Carolina and South Carolina. The company focuses on rural communities with a hybrid model that provides both primary and urgent care.
Resonetics provides laser micromachining manufacturing services for medical device and diagnostic companies, as well as other markets requiring precision laser processing of polymers and glass. The Company offers the world’s largest capacity for laser micromachining polymers in ultra-violet wavelengths and its expertise with polymers and with features as small as one micron is unmatched. The Company also designs, builds and services purpose-built laser workstations to meet specific customer needs. With more than 25 years of experience and a dedicated development lab staffed with PhDs, optical scientists and process experts, the Company delivers solutions for the most demanding polymer micromachining challenges.
RestorixHealth is a leading manager of comprehensive wound care treatment centers that offer advanced wound care modalities as well as hyperbaric oxygen therapy (“HBOt”). The Company manages wound care centers nationwide in partnership with local acute care hospitals. RestorixHealth was founded by physicians in 1997 with a focus on establishing in-hospital centers of excellence to treat the growing incidence of severe grade diabetic wounds of the lower extremities and wounds that are unresponsive to general wound care treatments. The Company’s centers have consistently achieved high treatment success rates, resulting in a dramatic increase in patient quality of life and significant cost savings to the healthcare system. Restorix was sold in 2015 to Leonard Green & Partners.
Island Medical Management
Island Medical Management, LLC is a clinically-led, privately-held organization with over 20 years of management experience. IMM’s unique model offers every advantage of a local community based group, backed by the resources of a national organization. The group provides services to over 75 hospital programs throughout the United States, with more than 1.6 million patient encounters each year. IMM is a portfolio company of New Mountain Capital, LLC, a New York based investment firm with over $15 billion in aggregate capital commitments.